Certara Announces Closing of Public Offering of Common Stock
November 22, 2021 17:45 ET
|
Certara
PRINCETON, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 10,000,000...
Global Biosimulation Global Market (2021 to 2030) - Featuring Certara, Dassault and Simulations Plus Among Others
November 18, 2021 07:28 ET
|
Research and Markets
Dublin, Nov. 18, 2021 (GLOBE NEWSWIRE) -- The "Biosimulation Global Market Report 2021: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering. This report...
Certara Appoints James E. Cashman III as Chairman of Board of Directors
November 08, 2021 16:30 ET
|
Certara
PRINCETON, N.J., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that James E. Cashman III, a current Board member, will be...
Certara to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
November 03, 2021 08:00 ET
|
Certara
PRINCETON, N.J., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William F. Feehery, Chief Executive Officer, and Andrew...
Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award
October 25, 2021 16:30 ET
|
Certara
PRINCETON, N.J., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that its Simcyp COVID-19 Vaccine Model has won an R&D 100...
Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021
October 19, 2021 08:00 ET
|
Certara
PRINCETON, N.J., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of...
Certara Appoints Drayton T. Virkler as Chief Commercial Officer
October 05, 2021 08:00 ET
|
Certara
PRINCETON, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Drayton T. Virkler to the newly created position...
Certara Completes Acquisition of Pinnacle 21
October 04, 2021 08:00 ET
|
Certara
PRINCETON, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the completion of the previously announced transaction to acquire...
Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission Process
September 30, 2021 16:30 ET
|
Certara
PRINCETON, N.J., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced the launch of Synchrogenix™ Writer, a new regulatory SaaS product that expedites the...
Certara Announces New Clinical Science Group and Adds Senior Scientific Experts
September 22, 2021 08:00 ET
|
Certara
PRINCETON, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced that it is expanding its Integrated Drug Development (IDD) division with a new clinical...